1. Moulton MJ, Creswell LL, Mackey ME, Cox JL, and Rosenbloom M. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg. 1996; 111: 1037-46
2. Henry D, Carless P, Fergusson D, and Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ. 2009; 180: 183-93
3. Mehr-Aein A, Sadeghi M, and Madani-civi M. Does tranexamic acid reduce blood loss in off-pump coronary artery bypass? Asian Cardiovasc Thorac Ann. 2007; 15: 285-9
4. Casati V, Della Valle P, Benussi S, et al. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg. 2004; 128: 83-91
5. Ngaage DL and Bland JM. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies. Eur J Cardiothorac Surg. 2010; 37: 1375-83
6. Murkin JM, Falter F, Granton J, et al. High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg. 2010; 110: 350-3
7. Tsementzis SA, Meyer CH, and Hitchcock ER. Cerebral blood flow in patients with a subarachnoid haemorrhage during treatment with tranexamic acid. Neurochirurgia (Stuttg). 1992; 35: 74-8
8. Myles PS, Smith JA, Forbes A, et al. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. N Engl J Med. 2017; 376: 136-148
9. Adler Ma SC, Brindle W, Burton G, et al. Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2011; 25: 26-35
10. Ahn SW, Shim JK, Youn YN, et al. Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery. Circ J. 2012; 76: 96-101
11. Chakravarthy M, Muniraj G, Patil S, et al. A randomized prospective analysis of alteration of hemostatic function in patients receiving tranexamic acid and hydroxyethyl starch (130/0.4) undergoing off pump coronary artery bypass surgery. Ann Card Anaesth. 2012; 15: 105-10
12. Greiff G, Stenseth R, Wahba A, et al. Tranexamic acid reduces blood transfusions in elderly patients undergoing combined aortic valve and coronary artery bypass graft surgery: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2012; 26: 232-8
13. Hassani E, Mahoori A, Mehdizadeh H, et al. The effects of tranexamic acid on postoperative bleeding in coronary artery bypass graft surgery. Tehran University Medical Journal. 2012; 70: 176-182
14. Nejad MHG, Baharestani B, Esfandiari R, Hashemi J, and Panahipoor A. Evaluation and comparison of using low-dose aprotinin and tranexamic acid in CABG: A double blind randomized clinical trial. Journal of Tehran University Heart Center. 2012; 7: 15-18
15. Wang G, Xie G, Jiang T, et al. Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. Anesth Analg. 2012; 115: 239-43
16. Esfandiari BR, Bistgani MM, and Kabiri M. Low dose tranexamic acid effect on post-coronary artery bypass grafting bleeding. Asian cardiovascular & thoracic annals. 2013; 21: 669-74
17. Shi J, Wang G, Lv H, et al. Tranexamic Acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: randomized trial and 1-year follow-up. Ann Thorac Surg. 2013; 95: 795-802
18. Yanartas M, Baysal A, Aydın C, et al. The effects of tranexamic acid and 6% hydroxyethyl starch (HES) solution (130/0.4) on postoperative bleeding in coronary artery bypass graft (CABG) surgery. International Journal of Clinical and Experimental Medicine. 2015; 8: 5959-5971
19. Moher D, Liberati A, Tetzlaff J, Altman DG, and Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009; 62: 1006-12
20. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343: d5928
21. Higgins JP GS. Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011].The Cochrane Collaboration.
22. Luo D, Wan X, Liu J, and Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018; 27: 1785-1805
23. Speekenbrink RG, Vonk AB, Wildevuur CR, and Eijsman L. Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting. Ann Thorac Surg. 1995; 59: 438-42
24. Brown RS, Thwaites BK, and Mongan PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial. Anesth Analg. 1997; 85: 963-70
25. Landymore RW, Murphy JT, Lummis H, and Carter C. The use of low-dose aprotinin, epsilon-aminocaproic acid or tranexamic acid for prevention of mediastinal bleeding in patients receiving aspirin before coronary artery bypass operations. Eur J Cardiothorac Surg. 1997; 11: 798-800
26. Hardy JF, Belisle S, Dupont C, et al. Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization. Ann Thorac Surg. 1998; 65: 371-6
27. Casati V, Gerli C, Franco A, et al. Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study. Ann Thorac Surg. 2001; 72: 470-5
28. Zabeeda D, Medalion B, Sverdlov M, et al. Tranexamic acid reduces bleeding and the need for blood transfusion in primary myocardial revascularization. Ann Thorac Surg. 2002; 74: 733-8
29. Jares M, Vanek T, Straka Z, and Brucek P. Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting. J Cardiovasc Surg (Torino). 2003; 44: 205-8
30. Pleym H, Stenseth R, Wahba A, et al. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesth Analg. 2003; 96: 923-8
31. Andreasen JJ and Nielsen C. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. Eur J Cardiothorac Surg. 2004; 26: 311-7
32. Karski J, Djaiani G, Carroll J, et al. Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: a prospective randomized controlled clinical trial. The Journal of thoracic and cardiovascular surgery, 2005; 130: 309-14
33. Vanek T, Jares M, Fajt R, et al. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2005; 28: 563-8
34. Santos AT, Kalil RA, Bauemann C, Pereira JB, and Nesralla IA. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. Braz J Med Biol Res. 2006; 39: 63-9
35. Wei M, Jian K, Guo Z, et al. Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass grafting. Scand Cardiovasc J. 2006; 40: 105-9
36. Maddali MM and Rajakumar MC. Tranexamic acid and primary coronary artery bypass surgery: a prospective study. Asian Cardiovasc Thorac Ann. 2007; 15: 313-9
37. Taghaddomi RJ, Mirzaee A, Attar AS, and Shirdel A. Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2009; 23: 312-5
38. Hashemi J, Ghaffari Nejad MH, Baharestani B, Esfandiari R, and Panahipoor A. Evaluation and comparison of use of low-dose aprotinin and tranexamic acid in CABG: A double-blind, prospective, randomized study of 150 patients. Iranian Heart Journal, 2011; 12: 40-4.
39. Alizadeh Ghavidel A, Totonchi Z, Chitsazan M, et al. Safety and efficacy of caproamin fides and tranexamic acid versus placebo in patients undergoing coronary artery revascularization. Journal of Cardiovascular and Thoracic Research. 2014; 6: 197-202
40. Rijken DC, de Munk GA, and Jie AF. Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength. Thromb Haemost. 1993; 70: 867-72
41. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985; 29: 236-61
42. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011: CD001886
43. Chesebro JH, Lam JY, and Fuster V. The pathogenesis and prevention of aortocoronary vein bypass graft occlusion and restenosis after arterial angioplasty: role of vascular injury and platelet thrombus deposition. J Am Coll Cardiol. 1986; 8: 57B-66B
44. Bourassa MG. Fate of venous grafts: the past, the present and the future. J Am Coll Cardiol. 1991; 17: 1081-3
45. Karski J, Djaiani G, Carroll J, et al. Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: a prospective randomized controlled clinical trial. J Thorac Cardiovasc Surg. 2005; 130: 309-14
46. Lin Z and Xiaoyi Z. Tranexamic acid-associated seizures: A meta-analysis. Seizure. 2016; 36: 70-3
47. Lecker I, Wang DS, Romaschin AD, et al. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest. 2012; 122: 4654-66
48. Kratzer S, Irl H, Mattusch C, et al. Tranexamic acid impairs gamma-aminobutyric acid receptor type A-mediated synaptic transmission in the murine amygdala: a potential mechanism for drug-induced seizures? Anesthesiology. 2014; 120: 639-49
49. Furtmuller R, Schlag MG, Berger M, et al. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect. J Pharmacol Exp Ther. 2002; 301: 168-73
50. Manji RA, Grocott HP, Leake J, et al. Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anaesth. 2012; 59: 6-13
51. Keyl C, Uhl R, Beyersdorf F, et al. High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. Eur J Cardiothorac Surg. 2011; 39: e114-21
52. Mirmohammadsadeghi A, Mirmohammadsadeghi M, and Kheiri M. Does topical tranexamic acid reduce postcoronary artery bypass graft bleeding? J Res Med Sci. 2018; 23: 6
53. Ali Shah MU, Asghar MI, Siddiqi R, et al. Topical application of tranexamic acid reduces postoperative bleeding in open-heart surgery: myth or fact? J Coll Physicians Surg Pak. 2015; 25: 161-5
54. Montroy J, Hutton B, Moodley P, et al. The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis. Transfus Med Rev. 2018; 32: 165-78